{"prompt": "['STABILITY 2', 'Version 1.4', 'PRO19020231', 'February 2, 2021', '7.1', 'Surgical Intervention', '45', '7.1.1 Anterior Cruciate Ligament Reconstruction', '47', '7.1.2 Graft Harvest', '49', '7.1.3', 'Lateral Extra-articular Tenodesis', '50', '7.2', 'Rationale for Specific Surgical Intervention', '51', '7.3', 'Alternative Treatments', '52', '7.4', 'Procedures for Training of Clinicians on Procedural Intervention', '52', '7.5', 'Monitoring Fidelity in Delivering the Intervention', '52', '7.6', 'Rehabilitation', '53', '7.6.1 Tissue Protection Phase', '54', '7.6.2', 'Motor Control Phase', '55', '7.6.3 Functional Optimization Phase', '56', '8', 'STUDY PROCEDURES AND MATERIALS', '57', '8.1', 'Consent Process', '57', '8.2', 'Screening', '57', '8.3', 'Randomization and Surgery', '58', '8.4', 'Rehabilitation', '59', '8.5', 'Clinical Follow-Up Appointments', '59', '8.5.1 Standard of Care Clinical Follow-Up Appointments', '59', '8.5.2 Research Activities at Clinical Follow-Up Appointments', '61', '8.6', 'Assessment of Outcomes', '63', '8.7', 'Subject Payment', '63', '9', 'POTENTIAL RISKS AND BENEFITS', '65', '9.1', 'Potential Risks Associated with Study Interventions', '65', '9.2', 'Potential Risks Associated with Study Tests', '66', '9.3', 'Potential Risks Associated with Privacy and Confidentiality', '67', '9.4', 'Potential Benefits', '68', '10', 'ASSESSMENT OF SAFETY', '69', '10.1', 'Definition of Adverse Events, Serious Adverse Events and Unanticipated', 'Problems', '69', '10.2', 'Reportable Events', '70', '11', 'ETHICS/PROTECTION OF HUMAN SUBJECTS', '73', '11.1', 'Ethical Standard', '73', '11.2', 'Institutional/Ethics Review Board', '73', '11.3', 'Informed Consent Process', '73', '11.4', 'Subject Confidentiality', '75', '12', 'STUDY OVERSIGHT', '76', '12.1', 'Composition of the Data and Safety Monitoring Board', '76', '12.2', 'Study Committees', '76', '13', 'CLINICAL SITE MONITORING PLAN', '80', '13.1', 'Clinical Monitoring Communication Plan', '80', '13.2', 'Scheduling of Visits', '81', '13.3', 'Types of Visits and Monitoring Activities', '81', '11']['STABILITY 2', 'Version 1.4', 'PRO19020231', 'February 2, 2021', '13.3.1 Site Initiation Visit', '81', '13.3.2 Interim Visits', '84', '13.3.3 For-Cause Visits', '85', '13.3.4 Close-Out Visit', '85', '13.4', 'Ongoing Site Monitoring and Documents to be Monitored', '86', '14', 'STATISTICAL CONSIDERATIONS', '89', '14.1', 'Study Hypotheses', '89', '14.2', 'Sample Size Considerations for Aim 1', '90', '14.2.1 For Sex-based Research Question', '91', '14.3', 'Sample Size Considerations for Aim 2', '92', '14.4', 'Sample Size Considerations for Aim 3', '92', '14.5', 'Plan for Data Analysis', '93', '14.5.1 Statistical Analysis for Aim 1', '93', '14.5.2 Statistical Analysis for Aims 2 and 3', '94', '14.5.3 Statistical Analysis for Aim 4', '95', '14.6', 'Handling Missing Data', '97', '15', 'SOURCE DOCUMENTS AND ACCESS TO SOURCE DATA/DOCUMENTS', '99', '16', 'DATA MANAGEMENT PLAN', '100', '16.1', 'Methods and Systems for Data Collection', '100', '16.2', 'Methods and Systems to Ensure Data Confidentiality and Subject Privacy', '105', '16.3', 'Data Sharing Agreement', '106', 'APPENDICES', '116', 'APPENDIX A: STUDY TIMELINE', '117', 'APPENDIX B: SCHEDULE OF EVENTS', '118', 'APPENDIX C: STUDY FORMS', '119', 'APPENDIX D: DATA SAFETY AND MONITORING BOARD TABLES', '120', '12']\n\n###\n\n", "completion": "END"}